11th Annual Event of the American Institute for Medical and Biological Engineering
New Horizons for Biology-Based Engineering
28 February 2002 - 3 March 2002
The National Academy of Sciences and The Westin Grand Hotel
Washington, DC
A broad, and until recently unconceivable, range of technologies is emerging from the
molecular and genomic revolutions in biological science. These biology-based
technologies extraordinary potential for addressing many issues facing our nation
today, including health care, bioterrorism, and enhancement of the quality of human
life.
The Eleventh Annual Event of the American Institute for Medical and Biological
Engineering (AIMBE) will focus on the exciting contributions, along with the inherent
technical and policy issues, capable of being offered by biological engineering
applied to some of the most crucial challenges currently being faced by society.
Will stem cell technologies fulfill their promise for transforming medicine? How can
microbial pathogens be detected and neutralized on a large population scale? Are there
ways to move beyond animal experimentation for studies of drugs and toxins for
therapeutics as well as chemical and biological weapons defense? These timely
questions are being addressed by biology-based engineering approaches, and will be
addressed in this meeting from the diverse perspectives of fundamental science,
applied technology, and public policy considerations.
In addition to the main program at the National Academy of Sciences, AIMBE's four
membership groups will host forums addressing the medical and biological community's
response to bioterrorism, the future of education and research in a post-Whitaker
Foundation world, the future public policy agenda for AIMBE, and the role of AIMBE
in addressing issues of importance to industry. As in prior years, the Annual Event
program will include a kick-off workshop, co-hosted by AIMBE and the National Science
Foundation, on Federal programs in medical and biological engineering.
Thursday, February 28, 2002 - The Westin Grand Hotel
Symposium, Federal Programs in Medical and Biological Engineering Understanding
ABET EC2000 - A Workshop for New Programs
Council of Chairs Meeting
Friday, March 1, 2002 - National Academy of Sciences
Session I. Stem Cells & Cell Based Therapeutics
Chair:
E. Terry Papoutsakis, Northwestern University
Speakers:
C. Eaves, University of British Columbia
P. Ossorio, University of Wisconsin
Session II. Microbial Pathogens: New Challenges, New Solutions
Chair:
George Georgiou, University of Texas, Austin
Speakers:
S.A. Johnson, University of Texas Southwestern Medical School
J. LaMontagne, National Institute of Allergic and Infectious Diseases
Session III. In Vitro Physiological Surrogates for Drug Safety and Efficacy Testing:
Opportunities and Impacts
Chair:
Linda Griffith, Massachusetts Institute of Technology
Speakers:
A. Rudolph, Defense Advanced Research Projects Agency
G. Kovacs, Stanford University
Keynote Address:
Marvin Cassman
Director, National Institute of General Medical Sciences
Induction - AIMBE Fellows, Class of 2002
Reception
Saturday, March 2, 2002 - The Westin Grand Hotel
Forum 1: "Bioterrorism: Medical and Biological Engineering's Response"
Hosted by AIMBE's Council of Societies
CHAIRS: Michael Ackerman and Warren Grundfest
AIMBE, through the Council of Societies, can play a positive and constructive role
in the dissemination of information and education to the public with regard to
technologies to deal with threats from bioterrorism . Each Society has experts in
many of the technical fields necessary to combat bioterrorism. These include, but are
not limited to: threat identification, detection systems, assessment of public risk,
public health measures, and therapeutic options. This forum brings speakers - selected
by the Council - to address these issues that are of critical importance in the war
against terrorism.
Forum 2: "AIMBE's Future Public Policy Agenda"
Hosted by AIMBE's College of Fellows
During its first decade of existence, AIMBE identified and addressed several key
public policy issues. These issues - federal support for research, medical device
regulation, and biomaterials access - have largely focused on achieving the enactment
of selected pieces of legislation by the US Congress. As we enter our second decade,
we face a host of legislative, regulatory, and societal issues that impact upon
cutting edge research conducted by medical and biological engineers, and the
improvement of the quality of life for the ultimate users of the technology we
invent. Based on issues raised at the main program yesterday, and through the results
of pre-Annual Event polling of the College of Fellows, this forum will address: 1)
the range of public policy issues that AIMBE's College of Fellows might address; 2)
mechanisms for addressing these public policy issues; and 3) specific measures for
including the College of Fellows in addressing selected issues.
Forum 3: "Academic Medical and Biological Engineering in a Post-Whitaker World"
Academic programs for medical and biological engineering have flourished over the past
25 years, supported generously by the Whitaker Foundation and several Federal
agencies, most notably the National Institutes of Health (NIH) and the National
Science Foundation (NSF). Major changes, however, lurk on the horizon. Most notably,
The Whitaker Foundation is entering its final stages of providing support prior to
closing in 2006, and the National Institute for Biomedical Imaging and Bioengineering
at NIH is in its first year of existence. What is the future of support for cutting
edge research in medical and biological engineering? This forum will include
presentations from the Whitaker Foundation, NIH, NSF, and a summary of Friday's
presentations from Federal agencies conducting support in the field.
Forum 4: Meeting the Needs of Industry
Hosted by AIMBE's Industry Council
College of Fellows Meeting
Reception
Annual Banquet
Sunday 3 March 2002 - The Westin Grand Hotel
AIMBE Council of Societies Meeting
AIMBE Academic Council Meeting
AIMBE Industry Council Meeting
AIMBE Board of Directors Meeting
|